Future Growth Prospects of the Bispecific Antibodies Market 2035
Despite favorable growth prospects, players operating within the Bispecific Antibodies Market must navigate significant therapeutic and commercial hurdles. High manufacturing complexity drives up cost-of-goods compared to standard monoclonal antibodies, compressing margins for smaller developers. Additionally, clinical risks like Cytokine Release Syndrome (CRS) and neurotoxicity require careful...
0 Comments 0 Shares 47 Views 0 Reviews